SEKISUI Diagnostics Invests (GBP)14.4 Million in cGMP Biopharm...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
BURLINGTON, Massachusetts, July 29, 2020 /PRNewswire-AsiaNet/ -- Sekisui announces the decision to invest (GBP)14.4 Million in its biopharma CDMO business aimed at cGMP microbial capacity expansion at the existing site in Maidstone, Kent to be completed by the second half of 2022. This investment follows the in...
Authors: LATEST ASIANET NEWS RELEASES